De- and re-differentiation of the melanocytic lineage

European Journal of Cell Biology
Lionel Larribere, Jochen Utikal

Abstract

Terminally differentiated cells can be reprogrammed by the transient, ectopic overexpression of different sets of genes into induced pluripotent stem cells (iPSCs). This process not only has considerable implications for regenerative medicine but is also highly relevant to multiple stages of oncogenesis, including melanoma. In other settings, the de-differentiation of normal and tumor cells is also responsible for a phenotype switch which completely changes the cell fate. Conversely, iPSCs as well as embryonic stem cells (ESCs) can be differentiated in vitro toward specific lineages, for example melanocytes, which offer useful models to investigate the genetic and epigenetic mechanisms involved in cellular differentiation. Here, we summarize recent findings regarding the reprogramming and de-differentiation of melanocytic cells as well as the latest differentiation protocols of pluripotent stem cells into the melanocyte lineage.

References

Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jamie M SpergerJames A Thomson
Aug 4, 2004·Genes & Development·Konrad HochedlingerRudolf Jaenisch
Nov 1, 1954·Proceedings of the National Academy of Sciences of the United States of America·L C Stevens, C C Little
Feb 9, 2007·Nature Biotechnology·Duncan E C BakerPeter W Andrews
Mar 8, 2007·Nature Reviews. Molecular Cell Biology·Robert J Klose, Yi Zhang
Nov 2, 2007·International Journal of Cancer. Journal International Du Cancer·Alexander RoeschThomas Vogt
Sep 12, 2008·Nature Reviews. Cancer·Jane E Visvader, Geoffrey J Lindeman
Sep 13, 2008·Cell Stem Cell·Nimet MaheraliKonrad Hochedlinger
Oct 22, 2008·Nature Biotechnology·Trond AasenJuan Carlos Izpisúa Belmonte
Apr 19, 2011·Experimental Dermatology·Anja Katrin BosserhoffSilke Kuphal
May 19, 2011·Experimental Dermatology·Marta Galach, Jochen Utikal
Jun 15, 2011·Cell·Stuart H Orkin, Konrad Hochedlinger
Aug 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xavier NissanChristine Baldeschi
Sep 24, 2011·Nature Reviews. Molecular Cell Biology·Martin Evans
Sep 29, 2011·Stem Cells·Susan E ZabierowskiMeenhard Herlyn
Nov 24, 2011·Nature Communications·Colin R LindsayOwen J Sansom
Jun 19, 2012·Cell Stem Cell·Shinya Yamanaka
Jul 10, 2012·Nature Cell Biology·Olga ShakhovaLukas Sommer
Sep 19, 2012·Molecular and Cellular Biology·Elise BonvinColin R Goding
Jan 26, 2013·Science·Susanne HornRajiv Kumar
Jan 26, 2013·Science·Franklin W HuangLevi A Garraway
Mar 30, 2013·Science·Mario L SuvàBradley E Bernstein
May 16, 2013·Nature Reviews. Molecular Cell Biology·Patrick Cahan, George Q Daley
Jun 25, 2013·Cancer Cell·Magalí Sáez-AyalaJosé Neptuno Rodríguez-López
Jul 9, 2013·Experimental and Molecular Pathology·Silke KuphalAnja K Bosserhoff

❮ Previous
Next ❯

Citations

Mar 8, 2019·Pigment Cell & Melanoma Research·Chieko HosakaChikako Nishigori
Apr 19, 2019·Molecular Carcinogenesis·Svetlana PaskašDanijela Maksimović-Ivanić
Jan 5, 2018·Oncotarget· SachindraJochen Utikal
Apr 1, 2015·Pigment Cell & Melanoma Research·Lionel LarribereJochen Utikal
May 8, 2016·Pigment Cell & Melanoma Research·Lionel Larribère, Jochen Utikal
May 24, 2019·Frontiers in Molecular Neuroscience·Lionel Larribère, Jochen Utikal
Nov 17, 2019·Ageing Research Reviews·Barbara Bellei, Mauro Picardo
Aug 8, 2021·Journal of Clinical Medicine·Lionel Larribère, Jochen Utikal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.